Beispiel: Heart Attack

Klinische Studien zur Shy-Drager-Syndrom

Insgesamt 122 ergebnisse

NCT03952806

Aktiv, nicht rekrutierend

Study of BHV-3241 in Subjects With Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT02185677

Abgeschlossen

Cognitive and Behavioral Dysexecutive Syndrome in Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT04680065

Noch nicht rekrutiert

GDNF Gene Therapy for Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT00750867

Abgeschlossen

Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins

Bedingungen: Multiple System Atrophy
NCT04250493

Rekrutierung

Insulin Resistance in Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT01146548

Abgeschlossen

Fluoxetine in Multiple System Atrophy Patients

Bedingungen: Multiple System Atrophy
NCT04287270

Abgeschlossen

Evaluation of Inspiratory Muscle Strength in Patients With Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT03403309

Abgeschlossen

Inosine 5'-Monophosphate to Raise of Serum Uric Acid Level in Patients With Multiple System Atrophy: a Multi-center, Randomized Controlled, Double Blind, Parallel Assigned Clinical Trial

Bedingungen: Multiple System Atrophy
NCT03811808

Rekrutierung

Multiple System Atrophy Multidisciplinary Clinic

Bedingungen: Multiple System Atrophy (MSA)
NCT04431713

Rekrutierung

Exenatide Once-weekly as a Treatment for Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT04165486

Rekrutierung

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB101 Administered to Adults With Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT03589976

Rekrutierung

A Futility Trial of Sirolimus in Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT03265444

Abgeschlossen

Safety and Tolerability of CS10BR05 Inj. in Subjects With Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT04450992

Rekrutierung

TRACK-MSA: A Longitudinal Study to Define Outcome Measures in Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT00997672

Beendet

Lithium in Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT01287221

Beendet

Study of Rifampicin in Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT01485549

Abgeschlossen

Oligomeric Alpha-synuclein in Multiple System Atrophy

Bedingungen: Multiple System Atrophy (MSA)
NCT04229173

Rekrutierung

Natural History and Disease Progression Biomarkers of Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT04617873

Rekrutierung

DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism

Bedingungen: Multiple System Atrophy, Parkinson Variant (Disorder)
NCT01136213

Abgeschlossen

Investigation of the Serotoninergic System in Multiple System Atrophy: a Positron Emission Tomography (PET) Study

Bedingungen: Multiple System Atrophy
NCT00911365

Abgeschlossen

Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Bedingungen: Multiple System Atrophy
NCT00977665

Abgeschlossen

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Bedingungen: Multiple System Atrophy
NCT01577992

Abgeschlossen

Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy

Bedingungen: Pain Threshold; Multiple System Atrophy
NCT01044992

Abgeschlossen

Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

Bedingungen: Multisystemic Atrophy
NCT02035761

Abgeschlossen

PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)

Bedingungen: Multiple System Atrophy - Parkinsonian Subtype (MSA-P); Multiple System Atrophy - Cerebellar Subtype (MSA-C)